Sales & Marketing News | pharmaphorum

News

GSK’s Omjjara EU-cleared for splenomegaly in myelofibrosis

GSK’s $1.9 billion takeover of Sierra Oncology has delivered the first new product, with the EU approval of Omjjara for the treatment of enlarged spleen (splenomegaly) or

News

Grifols sues Gotham City over fraud allegations

Spanish drugmaker Grifols has hit back at hedge fund Gotham City Research, which claimed it had fraudulently manipulated its financial reporting, with a lawsuit filed in N

News

CHMP turns down Neuraxpharm, Apellis drugs

The EMA’s human medicines committee refused marketing approvals for two drugs from Neuraxpharm and Apellis at its January meeting, but both companies have said they will a

News

Britain will be first to get new Mounjaro device, says Lilly

Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment

News

AbbVie invests $223m in Singapore biologics site

AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs.

News

AZ may get government aid for UK vaccines facility; report

The UK government is reportedly considering a financial aid package to encourage AstraZeneca to invest in an expansion of its vaccines manufacturing facility in Speke, nea

GSK’s Omjjara EU-cleared for splenomegaly in myelofibrosis

Grifols sues Gotham City over fraud allegations

CHMP turns down Neuraxpharm, Apellis drugs

Britain will be first to get new Mounjaro device, says Lilly

AbbVie invests $223m in Singapore biologics site

AZ may get government aid for UK vaccines facility; report

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks